Oncology Industry
Insights & Trends

April 27, 2020

Vaccines vs Treatment: Live Analysis of COVID-19 Trials

Today, #Kognitic opens public access to our insight-driven, live dashboard to keep abreast of all the #Covid19 clinical developments! Updated daily with data sourced directly from […]
April 26, 2020

Behind-the-Scenes Heroes of COVID-19

Behind-the-Scenes Heroes of COVID-19 #Kognitic would like to take a moment to thank the #researchers who are working unremittingly to find a #cure for #covid19. These […]
April 21, 2020

Kognitic Launches Innovative Map Feature to its Clinical Trial Intelligence Platform

Kognitic announces the launch of an innovative feature to its platform, one which allows its customers to plot the geographic location of active clinical trials into […]
April 21, 2020

Cancer Care in the Time of Covid-19

Cancer Care in the Time of Covid-19 While it seems much of our world has come to a halt since the spread of #covid19 , cancer […]
April 21, 2020

Kognitic Launches Covid-19 Insight Series

With over 1 million globally confirmed Covid-19 cases, the promise of bringing lives back to ‘normal’ seems ambiguous. Amidst several strategies to fight against the disease, […]
April 21, 2020

University of Penn Has Done It Again!

University of #Penn refuses to stop innovating. After having introduced CAR-T to the fight against #cancer, another Penn team has developed an a related technology which […]
April 21, 2020

Don’t Get Blindsided by Emerging Targets

Imalumab is the only drug targeting oxMIF to reach #clinicaltrials, but ultimately was terminated due to poor overall benefit-risk assessment. Now, OncoOne has announced that they […]
April 21, 2020

Tepotinib vs Capmatinib: A Race for Approval

Merck KGaA’s MET inhibitor, Tepotinib, received approval in Japan for #NSCLC yesterday, gaining a lead in the tight race against Capmatinib – Novartis’ MET inhibitor. The […]
April 21, 2020

Celebrating International Day of Women

On International Day of Women in Science. #Kognitic would like to celebrate the great strides which women are making in science. At our company women account […]